ArticleCellular & molecular immunology2022

A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern.

Jingyi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.